An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice

Abstract Background Patient reported outcome measurements (PROMs) are emerging as an important component of patient management in the cancer setting, providing broad perspectives on patients’ quality of life and experience. The use of PROMs is, however, generally limited to the context of randomised...

Full description

Bibliographic Details
Main Authors: Miss Charlotte L. Moss, Ajay Aggarwal, Asad Qureshi, Benjamin Taylor, Teresa Guerrero-Urbano, Mieke Van Hemelrijck
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:https://doi.org/10.1186/s12955-020-01648-x
id doaj-1e556adaa7314824be3bbfce3f9fb183
record_format Article
spelling doaj-1e556adaa7314824be3bbfce3f9fb1832021-01-17T12:19:10ZengBMCHealth and Quality of Life Outcomes1477-75252021-01-0119112010.1186/s12955-020-01648-xAn assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practiceMiss Charlotte L. Moss0Ajay Aggarwal1Asad Qureshi2Benjamin Taylor3Teresa Guerrero-Urbano4Mieke Van Hemelrijck5King’s College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), Guy’s HospitalComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustComprehensive Cancer Centre, Guy’s and St Thomas’ NHS Foundation TrustKing’s College London, School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), Guy’s HospitalAbstract Background Patient reported outcome measurements (PROMs) are emerging as an important component of patient management in the cancer setting, providing broad perspectives on patients’ quality of life and experience. The use of PROMs is, however, generally limited to the context of randomised control trials, as healthcare services are challenged to sustain high quality of care whilst facing increasing demand and financial shortfalls. We performed a systematic review of the literature to identify any oncological benefit of using PROMs and investigate the wider impact on patient experience, in cancers of the pelvic abdominal cavity specifically. Methods A systematic review of the literature was conducted using MEDLINE (Pubmed) and Ovid Gateway (Embase and Ovid) until April 2020. Studies investigating the oncological outcomes of PROMs were deemed suitable for inclusion. Results A total of 21 studies were included from 2167 screened articles. Various domains of quality of life (QoL) were identified as potential prognosticators for oncologic outcomes in cancers of the pelvic abdominal cavity, independent of other clinicopathological features of disease: 3 studies identified global QoL as a prognostic factor, 6 studies identified physical and role functioning, and 2 studies highlighted fatigue. In addition to improved outcomes, a number of included studies also reported that the use of PROMs enhanced both patient-clinician communication and patient satisfaction with care in the clinical setting. Conclusions This review highlights the necessity of routine collection of PROMs within the pelvic abdominal cancer setting to improve patient quality of life and outcomes.https://doi.org/10.1186/s12955-020-01648-xPatient reported outcome measurementsHealth related quality of lifePrognostic factorsOverall survivalPelvic abdominal cancers
collection DOAJ
language English
format Article
sources DOAJ
author Miss Charlotte L. Moss
Ajay Aggarwal
Asad Qureshi
Benjamin Taylor
Teresa Guerrero-Urbano
Mieke Van Hemelrijck
spellingShingle Miss Charlotte L. Moss
Ajay Aggarwal
Asad Qureshi
Benjamin Taylor
Teresa Guerrero-Urbano
Mieke Van Hemelrijck
An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
Health and Quality of Life Outcomes
Patient reported outcome measurements
Health related quality of life
Prognostic factors
Overall survival
Pelvic abdominal cancers
author_facet Miss Charlotte L. Moss
Ajay Aggarwal
Asad Qureshi
Benjamin Taylor
Teresa Guerrero-Urbano
Mieke Van Hemelrijck
author_sort Miss Charlotte L. Moss
title An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
title_short An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
title_full An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
title_fullStr An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
title_full_unstemmed An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
title_sort assessment of the use of patient reported outcome measurements (proms) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
publisher BMC
series Health and Quality of Life Outcomes
issn 1477-7525
publishDate 2021-01-01
description Abstract Background Patient reported outcome measurements (PROMs) are emerging as an important component of patient management in the cancer setting, providing broad perspectives on patients’ quality of life and experience. The use of PROMs is, however, generally limited to the context of randomised control trials, as healthcare services are challenged to sustain high quality of care whilst facing increasing demand and financial shortfalls. We performed a systematic review of the literature to identify any oncological benefit of using PROMs and investigate the wider impact on patient experience, in cancers of the pelvic abdominal cavity specifically. Methods A systematic review of the literature was conducted using MEDLINE (Pubmed) and Ovid Gateway (Embase and Ovid) until April 2020. Studies investigating the oncological outcomes of PROMs were deemed suitable for inclusion. Results A total of 21 studies were included from 2167 screened articles. Various domains of quality of life (QoL) were identified as potential prognosticators for oncologic outcomes in cancers of the pelvic abdominal cavity, independent of other clinicopathological features of disease: 3 studies identified global QoL as a prognostic factor, 6 studies identified physical and role functioning, and 2 studies highlighted fatigue. In addition to improved outcomes, a number of included studies also reported that the use of PROMs enhanced both patient-clinician communication and patient satisfaction with care in the clinical setting. Conclusions This review highlights the necessity of routine collection of PROMs within the pelvic abdominal cancer setting to improve patient quality of life and outcomes.
topic Patient reported outcome measurements
Health related quality of life
Prognostic factors
Overall survival
Pelvic abdominal cancers
url https://doi.org/10.1186/s12955-020-01648-x
work_keys_str_mv AT misscharlottelmoss anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT ajayaggarwal anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT asadqureshi anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT benjamintaylor anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT teresaguerrerourbano anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT miekevanhemelrijck anassessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT misscharlottelmoss assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT ajayaggarwal assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT asadqureshi assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT benjamintaylor assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT teresaguerrerourbano assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
AT miekevanhemelrijck assessmentoftheuseofpatientreportedoutcomemeasurementspromsincancersofthepelvicabdominalcavityidentifyingoncologicbenefitandanevidencepracticegapinroutineclinicalpractice
_version_ 1724335098366525440